#Ep 5: The Consistent Compounders Show :Stay tuned to catch Saurabh Mukherjea in conversation with Sohini Andani, Fund Manager, SBI Mutual Fund.

Buy Healthcare Global Enterprises; target of Rs 310: Edelweiss

Edelweiss is bullish on Healthcare Global Enterprises has recommended buy rating on the stock with a target price of Rs 310 in its research report dated May 25, 2017.

June 09, 2017 / 07:58 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Edelweiss' research report on Healthcare Global Enterprises


Healthcare Global (HCG) reported in-line Q4FY17 with revenue and EBITDA growing 18% and 20% YoY, respectively. Existing oncology centers posted 17% YoY growth in revenue, while the new centres continued strong ramp up thereby reducing their EBITDA loss to INR 9mn (INR 14mn loss in Q3FY17).


Outlook


We expect debt and capex to peak at INR 2bn and INR 5.1bn, respectively, by FY18 to fund expansion plans. In our view, HCG is positioned for robust EBITDA growth owing to strong therapy tailwind and EBITDA margin levers. We maintain ’BUY’ with a target price of INR 310 (18x FY19E EV/EBITDA).


For all recommendations, click here


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

first published: May 26, 2017 04:46 pm

stay updated

Get Daily News on your Browser
Sections